• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Who should treat patients with opioid use disorder?

Bioengineer by Bioengineer
July 10, 2017
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a Point/Counterpoint, two doctors debate whether or not family physicians should provide medication-assisted treatment to their patients with opioid use disorder. Family physician David Loxterkamp states that family medicine, with its focus on relationships, communities, and team-based care, must be at the forefront of treating patients touched by this epidemic. Because family physicians know how to listen, care, and be present for their patients, Loxterkamp contends, they are well-qualified to treat addiction. In contrast, psychiatrist Richard Hill states that patients requiring medication assisted treatment need care from highly trained specialists in addiction medicine or addiction psychiatry who can treat both substance use disorder and co-morbid psychiatric disorders. Adding treatment for substance use disorder to the responsibilities of an already-overextended primary care workforce, Hill states, is an undue clinical burden.

Editorialists Richard Saitz and Timothy Daaleman contend that substance use disorder can only be treated successfully if primary care is a strong point of entry to care. Primary care physicians must be responsible for the initial and longitudinal care of patients with substance use disorders, and specialized services must be widely available and accessible. "Our nation will not be able to adequately respond to the current epidemic without addressing it in primary care and there is no question that the time to do it is now," they write.

###

Medication-Assisted Treatment Should Be Part of Every Family Physician's Practice: Yes
David Loxterkamp, MD, Belfast, Maine http://www.annfammed.org/content/15/4/309

Medication-Assisted Treatment Should Be Part of Every Family Physician's Practice: No
Richard R. Hill, MD, PhD, Case Western Reserve University School of Medicine
http://www.annfammed.org/content/15/4/310

Now is the Time to Address Substance Use Disorders in Primary Care
Richard Saitz, MD, MPH, FACP, DFASAM, Boston University School of Public Health Timothy P. Daaleman, DO, MPH, University of North Carolina at Chapel Hill
http://www.annfammed.org/content/15/4/306

Media Contact

Janelle Davis
[email protected]
913-906-6000 x5222
@annfammed

http://www.annfammed.org

Share12Tweet8Share2ShareShareShare2

Related Posts

Inequities in Family Engagement Within the NICU

April 1, 2026

Frailty, Malnutrition Link Falls to Daily Functioning

April 1, 2026

Dactylides D, E: Novel 22-Membered Polyol Macrolides

April 1, 2026

Cutting-Edge “Smart” Drugs Revolutionize Cancer Treatment

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unveiling the Biological Pathways Linking Pesticides to Cancer Risk: New Study Sheds Light on Environmental Health Impacts

Inequities in Family Engagement Within the NICU

FGFR2b Links to Biomarkers, Tumor Diversity, Survival

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.